Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 14/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 14/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 11/20 | 0.44 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17346431 | 0.99 | ACHE (0.48) | ACHEOPRM1OPRK1OPRD1DRD2 | |
| SCHEMBL17346447 | 0.90 | OPRM1 (0.44) | ACHEOPRM1OPRK1OPRD1DRD2 | |
| SCHEMBL17346365 | 0.89 | OPRM1 (0.43) | ACHEOPRM1OPRK1OPRD1ALDH1A1 | |
| SCHEMBL17346243 | 0.88 | ACHE (0.45) | ACHEOPRM1OPRK1OPRD1DRD2 | |
| SCHEMBL17346168 | 0.87 | ACHE (0.47) | ACHEOPRM1OPRK1OPRD1DRD3 | |
| SCHEMBL17345895 | 0.85 | OPRM1 (0.40) | ACHEOPRM1OPRK1OPRD1ALDH1A1 | |
| SCHEMBL17345882 | 0.85 | ALDH1A1 (0.44) | OPRM1DRD3ALDH1A1HPGDLMNA | |
| SCHEMBL17345881 | 0.84 | OPRM1 (0.39) | ACHEOPRM1OPRK1OPRD1ALDH1A1 | |
| SCHEMBL17346146 | 0.82 | OPRM1 (0.37) | ACHEOPRM1OPRK1OPRD1ALDH1A1 | |
| SCHEMBL17346156 | 0.82 | OPRM1 (0.37) | ACHEOPRM1OPRK1OPRD1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10550139-B2 | Polydentate ligands and their complexes for molecular catalysis | TRIAD NATIONAL SECURITY, LLC (US) | 2020-02-04 | — | — | US | disclosed |
| US-20170088571-A1 | POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS | TRIAD NATIONAL SECURITY, LLC | 2017-03-30 | — | — | US | disclosed |
| US-20170088571-A1 | POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS | TRIAD NATIONAL SECURITY, LLC | 2017-03-30 | — | — | US | disclosed |
| WO-2015191505-A1 | POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2015-12-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170088571-A1 | POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS | NANS, NCL, NCLN | ACHE 1215/4885OPRM1 274/4885OPRK1 171/4885 |
| US-10550139-B2 | Polydentate ligands and their complexes for molecular catalysis | NANS, NCL, NCLN | ACHE 1215/4885OPRM1 274/4885OPRK1 171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.